Novavax’s 3,500% Surge on a Covid-19 Vaccine Faces First Test
(Bloomberg) -- Novavax Inc.’s Covid-19 vaccine results are expected imminently and scientists will be scanning the data to gauge the shot’s promise. At the same time, day traders -- who’ve snapped ...